R M Mason, C A Lancaster
Index: Biochem. J. 281 ( Pt 2) , 525-31, (1992)
Full Text: HTML
1. Cyclofenil diphenol (F6060), a weak non-steroidal oestrogen, was shown previously to inhibit [35S]proteoglycan synthesis [Mason, Lineham, Phillipson & Black (1984) Biochem. J. 223, 401-412] and to induce fragmentation of the Golgi apparatus into small vesicles [Lancaster, Fryer, Griffiths & Mason (1989) J. Cell Sci. 92, 271-280] in cultures of Swarm chondrosarcoma chondrocytes. Two structurally related compounds, F6204 and F6091, show a similar concentration-related effect, with complete inhibition of [35S]proteoglycan synthesis at 90 micrograms/ml. The apparent [3H]protein synthesis is only approx. 40% inhibited with [3H]lysine as precursor. Stilboestrol, clomiphene and tamoxiphen are also potent inhibitors of [35S]proteoglycan synthesis. 2. Syntheses of chondroitin 4-[35S]sulphate and chondroitin 6-[35S]sulphate, which are Golgi-mediated events, are inhibited 40-68% and 3-48% respectively by concentrations of cyclofenil between 50 and 70 micrograms/ml. [3H]Hyaluronan synthesis, which occurs by a different mechanism at the plasma membrane, is inhibited by 47-66%. These results suggest that cyclofenil may act via more than one inhibitory mechanism. Cyclofenil diphenol inhibits polymerization of chondroitin sulphate on to p-nitrophenyl beta-xyloside even when the chondrocytes are loaded with the initiator prior to treatment. 3. Cyclofenil diphenol interferes with the cellular uptake of amino acids via the system A carrier, as shown by inhibition of uptake of methylaminoisobutyric acid, a specific substrate for this system. The drug had no effect on the uptake of 2-deoxyglucose by the cells. 4. Cyclofenil diphenol (90 micrograms/ml) caused a decrease in the pool size of UDP-N-acetylglucosamine, UDP-N-acetylgalactosamine and UDP-hexoses, but this was insufficient to account for the accompanying profound inhibition of [35S]proteoglycan synthesis. Entry of [3H]glucosamine into the cell and into the UDP-N-acetylhexosamine pool did not appear to be affected. 5. Cyclofenil diphenol inhibited the substitution of 3H-labelled proteoglycan core protein with chondroitin sulphate chains. Core protein was identified in treated cultures on the basis of immunoprecipitation with an antiserum against the hyaluronate-binding region and distinguished from precipitated proteoglycan on SDS/PAGE.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Cyclofenil
CAS:2624-43-3 |
C23H24O4 |
A misguided 'pill in the pocket' approach with flecainide le...
2012-01-01 [BMJ Case Rep. 2012 , doi:10.1136/bcr-2012-006868, (2012)] |
Exploration of the bicyclo[3.3.1]nonane system as a template...
2003-12-15 [Bioorg. Med. Chem. Lett. 13(24) , 4485-8, (2003)] |
Synthesis of new carbon-11 labeled cyclofenil derivatives fo...
2008-04-01 [Appl. Radiat. Isot. 66(4) , 523-9, (2008)] |
Synthesis and biodistribution of fluorine-18-labeled fluoroc...
2007-05-01 [Nucl. Med. Biol. 34(4) , 383-90, (2007)] |
Retrograde trafficking of both Golgi complex and TGN markers...
1998-04-01 [J. Cell Sci. 111 ( Pt 7) , 951-65, (1998)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved